 |
Clazosentan |
|---|---|
| Trade Name | Erajet |
| Orphan Indication | Cerebral vasospasm following subarachnoid hemorrhage |
| USA Market Approval | USA |
| USA Designation Date | 2006-02-16 00:00:00 |
| Sponsor | Idorsia Pharmaceuticals US Inc.;1820 Chapel Avenue West, Suite 150;Cherry Hill, New Jersey, 08002 |
